DiscoverJAMA Cardiology Author InterviewsViability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction
Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction

Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction

Update: 2023-10-251
Share

Description

Interview with Divaka Perera, MA, MD, author of Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction: A Prespecified Secondary Analysis of the REVIVED-BCIS2 Trial, and Julio A. Panza, MD, author of Assessment of Myocardial Viability in Ischemic Cardiomyopathy—Scarred by the Data but Still Alive. Hosted by James E. Udelson, MD.

Related Content:

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction

Viability and Outcomes With Revascularization or Medical Therapy in Ischemic Ventricular Dysfunction